Literature DB >> 30835

Mechanism of fluorometric analysis of tetracycline involving metal complexation.

S T Day, W G Crouthamel, L C Martinelli, J K Ma.   

Abstract

Tetracycline complexation with calcium and organic ligands was studied using fluorescence, circular dichroism, and solvent extraction methods. The results were used to interpret the mechanism of the commonly used fluorometric methods for the analysis of tetracycline in biological fluids. Tetracycline formed ternary calcium complexes with barbital sodium and L-tryptophan in alkaline solutions. The circular dichroism studies indicate that the calcium ion in these complexes is bound to the C-4 dimethylamino and the C-12a hydroxyl groups of tetracycline. These ternary complexes are strongly fluorescent and can be extracted easily into 1-butanol or ethyl acetate. Based on the characteristics of the ternary complexes and of the tetracycline degradation products, it is concluded that only the active form of tetracycline can be complexed and extracted for fluorescence analysis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 30835     DOI: 10.1002/jps.2600671107

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  3 in total

1.  Comparison of bone formation rates measured by radiocalcium kinetics and double-tetracycline labeling in maintenance dialysis patients.

Authors:  M Cochran; M Cochran; A Neville; E A Marshall
Journal:  Calcif Tissue Int       Date:  1994-05       Impact factor: 4.333

2.  pH-dependent spectroscopy of tetracycline and its analogs.

Authors:  Elmer-Rico E Mojica; Eric Nguyen; Mariya Rozov; Frank V Bright
Journal:  J Fluoresc       Date:  2014-05-09       Impact factor: 2.217

3.  Metal ion-tetracycline interactions in biological fluids. Part 3. Formation of mixed-metal ternary complexes of tetracycline, oxytetracycline, doxycycline and minocycline with calcium and magnesium, and their involvement in the bioavailability of these antibiotics in blood plasma.

Authors:  L Lambs; M Brion; G Berthon
Journal:  Agents Actions       Date:  1984-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.